Topic

Natpara (parathyroid hormone)

A collection of 21 issues

Myths vs. Facts: Getting Natpara (Parathyroid Hormone) Covered by Aetna CVS Health in Michigan

Important Update: Takeda will permanently discontinue all Natpara shipments on December 31, 2025. New patient starts are typically denied due to no commercial supply. If you're currently on Natpara through the Special Use Program, work with your endocrinologist immediately to plan your transition to alternatives like Yorvipath or

How to Get Natpara (Parathyroid Hormone) Covered by Cigna in Pennsylvania: Complete Requirements Guide

Answer Box: Getting Natpara Covered by Cigna in Pennsylvania Who's eligible: Adults with chronic hypoparathyroidism who've failed maximized calcium and vitamin D therapy, with documented low PTH levels on two separate tests. Fastest path to approval: 1. Submit prior authorization through CignaforHCP.com with complete lab

How to Get Natpara (Parathyroid Hormone) Covered by Aetna CVS Health in Ohio: 2025 Discontinuation Guide

Answer Box: Natpara Coverage with Aetna CVS Health in Ohio Critical Update: Takeda permanently discontinued Natpara manufacturing in 2024. The U.S. Special Use Program ends December 31, 2025. For existing patients in Ohio with Aetna CVS Health coverage: 1. Verify current coverage through your CVS Caremark member portal or

How to Get Natpara (Parathyroid Hormone) Approved by UnitedHealthcare in North Carolina: Complete Timeline & Appeals Guide

Answer Box: Getting Natpara Approved by UnitedHealthcare in North Carolina Important Update: Takeda permanently discontinued Natpara manufacturing in December 2024, with the Special Use Program ending December 31, 2025. New patient approvals are extremely unlikely due to lack of commercial supply. For existing patients: UnitedHealthcare typically requires 1-15 business days

How to Get Natpara (Parathyroid Hormone) Covered by Cigna in Washington: Complete 2025 Discontinuation Guide

Answer Box: Getting Natpara Covered by Cigna in Washington Critical Update: Natpara was discontinued by Takeda on December 31, 2024. Existing patients have access through the Special Use Program until December 31, 2025, but new prescriptions are generally denied due to lack of commercial supply. For current patients: Submit prior

How to Get Natpara (Parathyroid Hormone) Covered by Blue Cross Blue Shield in Pennsylvania: Appeals Guide with Forms and Timelines

Answer Box: Getting Natpara Covered in Pennsylvania Important Update: Takeda discontinued Natpara manufacturing globally, with the U.S. Special Use Program ending December 31, 2025. New prescriptions are typically denied due to lack of commercial supply. For existing patients transitioning off Natpara, Pennsylvania's external review program offers strong

If Natpara Isn't Approved by Blue Cross Blue Shield in Michigan: Formulary Alternatives & Exception Paths (2025 Discontinuation Guide)

Answer Box: Natpara Coverage in Michigan (2025 Update) Natpara is permanently discontinued as of December 31, 2025, with no new patient starts allowed. Blue Cross Blue Shield of Michigan members should focus on Yorvipath (palopegteriparatide) as the FDA-approved alternative, or optimized calcium/calcitriol therapy. First step today: Contact your endocrinologist

How to Get Natpara (Parathyroid Hormone) Covered by Humana in Georgia: Prior Authorization, Appeals, and Cost Options

Quick Answer: Getting Natpara Covered by Humana in Georgia Critical Update: Natpara manufacturing ended globally in 2024, with U.S. supply ending December 31, 2025. New patient starts are generally denied due to limited availability through Takeda's Special Use Program. For existing patients: Humana covers Natpara with prior

The Requirements Checklist to Get Natpara (Parathyroid Hormone) Covered by Aetna (CVS Health) in California

Quick Answer: Getting Natpara (parathyroid hormone) covered by Aetna (CVS Health) in California requires prior authorization with strict clinical documentation. You'll need confirmed hypoparathyroidism diagnosis, failed calcium/vitamin D therapy records, and endocrinologist support. Important: Takeda discontinued Natpara manufacturing globally in late 2024, with U.S. supply ending

How to Get Natpara (Parathyroid Hormone) Covered by Blue Cross Blue Shield in Virginia: Complete Requirements Guide and Appeals Process

Answer Box: Getting Natpara Covered by Blue Cross Blue Shield in Virginia Natpara (parathyroid hormone) requires prior authorization from Blue Cross Blue Shield Virginia plans. However, Takeda discontinued global manufacturing in 2024, with U.S. supply ending December 31, 2025. New starts are typically denied due to lack of commercial